arsenic has been researched along with Neutropenia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Fukuhara, N; Izutsu, K; Kang, HJ; Kim, WS; Ko, PS; Kwong, YL; Nagahama, F; Nagai, H; Nakajima, H; Negoro, E; Sonehara, Y; Suehiro, Y; Terui, Y; Tien, HF; Tobinai, K; Uchida, T; Yamamoto, K; Yoon, DH | 1 |
| Amadori, S; Avvisati, G; Brandts, CH; Breccia, M; Carella, AM; Cazzola, M; Cerqui, E; Cicconi, L; Ciceri, F; Di Bona, E; Divona, M; Döhner, H; Döhner, K; Ehninger, G; Fabbiano, F; Fazi, P; Ferrara, F; Fiedler, W; Finizio, O; Fioritoni, G; Ganser, A; Hänel, M; Hertenstein, B; Iacobelli, S; Kropp, MG; La Nasa, G; Levis, A; Link, H; Lo-Coco, F; Lübbert, M; Luppi, M; Mandelli, F; Melillo, L; Morra, E; Orlando, SM; Platzbecker, U; Rambaldi, A; Salih, HR; Sauer, M; Schlenk, RF; Schmitz, N; Sica, S; Specchia, G; Thiede, C; Venditti, A; Vignetti, M; von Lilienfeld-Toal, M; Wattad, M | 1 |
| Fan, S; Han, X; Hou, J; Hu, L; Li, J; Li, L; Li, X; Liu, X; Lv, C; Wang, S; Zhang, Y; Zhao, Y; Zhou, J; Zhu, L | 1 |
| Anaissie, E; Badros, A; Barlogie, B; Desikan, R; Morris, C; Munshi, NC; Toor, A; Tricot, G; Zangari, M | 1 |
| Cheng, AL; Hsu, C; Hsu, CH; Hsu, WL; Lin, CC; Yang, CH | 1 |
| Audebert, AA; Canuel, C; Debray, J; Decroix, JP; Genot, JY; Krulik, M | 1 |
| BAUER, WH | 1 |
5 trial(s) available for arsenic and Neutropenia
| Article | Year |
|---|---|
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study.
Topics: Arsenicals; Glutathione; Humans; Lymphoma, T-Cell, Peripheral; Neutropenia | 2023 |
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Consolidation Chemotherapy; Disease-Free Survival; Female; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Male; Middle Aged; Neutropenia; Oxides; Thrombocytopenia; Tretinoin; Young Adult | 2013 |
Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia.
Topics: Adolescent; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Neutropenia; Oxides; Remission Induction; Time Factors | 2010 |
Clinical activity of arsenic trioxide for the treatment of multiple myeloma.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Drug Evaluation; Humans; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neutropenia; Oxides; Salvage Therapy; Treatment Outcome | 2002 |
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Administration Schedule; Fatigue; Female; Humans; Injections, Intravenous; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxides; Survival Analysis; Treatment Outcome | 2007 |
2 other study(ies) available for arsenic and Neutropenia
| Article | Year |
|---|---|
[Erythroderma and leukoneutropenia induced by arsenic during the treatment of lichen planus].
Topics: Agranulocytosis; Arsenicals; Dermatitis, Exfoliative; Female; Humans; Lichen Planus; Middle Aged; Neutropenia | 1981 |
The supporting tissues of the tooth in acute secondary agranulocytosis (arsphenamin neutropenia).
Topics: Agranulocytosis; Arsenic; Humans; Neutropenia | 1946 |